The divergence between major indices and smaller firms has widened significantly, with dozens of niche players posting triple-digit gains despite overarching market declines. Surging requirements for data centres, artificial intelligence, and communications hardware propelled the sharpest individual rallies, alongside strength in defence and consumer sectors. This momentum has pushed smallcap valuations to 32.5 times trailing earnings, prompting portfolio managers to emphasize disciplined allocations over immediate gains.
Key points
Elevated smallcap price multiples necessitate a selective focus on businesses demonstrati…: Elevated smallcap price multiples necessitate a selective focus on businesses demonstrating verifiable earnings growth that supports current prices.
A five-year systematic investment plan is recommended by market strategists to effectivel…: A five-year systematic investment plan is recommended by market strategists to effectively manage broader volatility and foreign flow pressures.
Broad index performance can obscure robust sectoral expansions within targeted segments s…: Broad index performance can obscure robust sectoral expansions within targeted segments such as engineering, defence, and communications infrastructure.
Sources checked by our analysis pipeline: 1
The Nifty has fallen 11% since the last Diwali, while the Smallcap 100 has fared better, gaining 2.8%. An analysis of stock returns since last Diwali shows that 60 companies have delivered gains exceeding 100%, outperforming both the benchmark and the broader smallcap index.
For all LIVE market updates, click here
Sterlite Technologies leads with 650% rally
Sterlite Technologies emerged as the biggest winner in the list, with its shares surging 649.7% since the last Diwali. The optical connectivity and digital infrastructure company has benefited from growing investor interest in businesses linked to data centres, artificial intelligence and communications infrastructure.Cupid followed with a 527% rally, while Sigma Advanced Systems gained 464.4%, making them the only three stocks in the list to deliver returns exceeding 400%.
Pharmaceutical stocks also featured prominently among the biggest winners. Bliss GVS Pharma surged 316.6%, while Kwality Pharmaceuticals gained 312.9%. Ind-Swift Laboratories advanced 259.6%, and Shilpa Medicare climbed 152.5%.
Defence, engineering and telecom stocks deliver big gains
Industrial and infrastructure-related companies were another major source of multibagger returns. Swan Defence and Heavy Industries gained 262.9%, while…
Market analysts project substantial quarterly gains for the conglomerate, primarily driven by a sharp rebound in its core refining and petrochemical operations. Although near-term equity performance has weakened, operational tailwinds such as favorable middle-distillate cracks and currency depreciation are counterbalancing headwinds in the retail division. Consequently, technical analysts view the recent valuation dip as an attractive entry level backed by defined recovery targets.
International development data indicates that nationwide economic momentum has drastically reduced the share of citizens living in severe hardship over more than a decade. The World Bank attributes this transformation to broad-based economic drivers, including rising consumer spending and robust workforce expansion. Notably, heightened employment access for female workers served as a critical pillar in driving this substantial social and financial progress.
Strong operational turnarounds in the September quarter triggered a sharp rebound for the newly independent energy units spun off from the parent conglomerate in June. Both entities reversed prior-year losses through higher revenues and improved operating margins. However, the surge only partially cushions longer-term declines, as both equities remain substantially depressed compared to their initial market debut prices.